Gender differences in HIV-1 diversity at time of infection
about
The spread, treatment, and prevention of HIV-1: evolution of a global pandemicEvolution of proviral gp120 over the first year of HIV-1 subtype C infectionThe Antibody Response against HIV-1Origin of the transmitted virus in HIV infection: infected cells versus cell-free virusEvidence for Within-Host Genetic Recombination among the Human Pegiviral Strains in HIV Infected SubjectsUse of a high resolution melting (HRM) assay to compare gag, pol, and env diversity in adults with different stages of HIV infectionIdentification and characterization of transmitted and early founder virus envelopes in primary HIV-1 infectionMemory CD4(+) T cells are the earliest detectable human immunodeficiency virus type 1 (HIV-1)-infected cells in the female genital mucosal tissue during HIV-1 transmission in an organ culture system.Population genetic estimation of the loss of genetic diversity during horizontal transmission of HIV-1.Inflammatory genital infections mitigate a severe genetic bottleneck in heterosexual transmission of subtype A and C HIV-1Complexity of the inoculum determines the rate of reversion of SIV Gag CD8 T cell mutant virus and outcome of infection.Targeting Trojan Horse leukocytes for HIV prevention.High Multiplicity Infection by HIV-1 in Men Who Have Sex with Men.Retroviral recombination in vivo: viral replication patterns and genetic structure of simian immunodeficiency virus (SIV) populations in rhesus macaques after simultaneous or sequential intravaginal inoculation with SIVmac239Deltavpx/Deltavpr and SIHIV-1 Transmission, Replication Fitness and Disease Progression.Selection for human immunodeficiency virus type 1 envelope glycosylation variants with shorter V1-V2 loop sequences occurs during transmission of certain genetic subtypes and may impact viral RNA levels.The genotype of early-transmitting HIV gp120s promotes α (4) β(7)-reactivity, revealing α (4) β(7) +/CD4+ T cells as key targets in mucosal transmission.Population genetic analysis of the protease locus of human immunodeficiency virus type 1 quasispecies undergoing drug selection, using a denaturing gradient-heteroduplex tracking assay.Route of simian immunodeficiency virus inoculation determines the complexity but not the identity of viral variant populations that infect rhesus macaques.Wide variation in the multiplicity of HIV-1 infection among injection drug usersLow human immunodeficiency virus envelope diversity correlates with low in vitro replication capacity and predicts spontaneous control of plasma viremia after treatment interruptions.Association of HIV diversity and survival in HIV-infected Ugandan infants.Recommendations for the design and use of standard virus panels to assess neutralizing antibody responses elicited by candidate human immunodeficiency virus type 1 vaccinesEvidence for frequent reinfection with human immunodeficiency virus type 1 of a different subtype.Validation of a modified commercial enzyme-linked immunoassay for detection of human immunodeficiency virus type 1 immunoglobulin G antibodies in saliva.Identifying and characterizing recently transmitted viruses.A comparison of parallel pyrosequencing and sanger clone-based sequencing and its impact on the characterization of the genetic diversity of HIV-1.Susceptibility to human immunodeficiency virus-1 infection of human foreskin and cervical tissue grown in explant cultureHIV-1 transmission biology: selection and characteristics of infecting viruses.Relative replication capacity of phenotypic SIV variants during primary infections differs with route of inoculation.Regional clustering of shared neutralization determinants on primary isolates of clade C human immunodeficiency virus type 1 from South Africa.Compartmentalization of surface envelope glycoprotein of human immunodeficiency virus type 1 during acute and chronic infection.Intrapatient diversity and its correlation with viral setpoint in human immunodeficiency virus type 1 CRF02_A/G-IbNG infection.Human immunodeficiency virus type 1 env evolves toward ancestral states upon transmission to a new host.Differential selection of specific human immunodeficiency virus type 1/JC499 variants after mucosal and parenteral inoculation of chimpanzees.Virus population homogenization following acute human immunodeficiency virus type 1 infectionHuman immunodeficiency virus type 1 (HIV-1) diversity at time of infection is not restricted to certain risk groups or specific HIV-1 subtypes.Human immunodeficiency virus type 1 superinfection was not detected following 215 years of injection drug user exposure.Human immunodeficiency virus superinfection and recombination: current state of knowledge and potential clinical consequences.Antibody maturation and viral diversification in HIV-infected women.
P2860
Q22241890-936B1E2A-D945-4C99-BCF4-60186490FD0AQ24653373-7BB1F19F-E9E7-44DE-82C4-47435F4DF949Q27000889-FDD10E63-29E4-4190-91BB-C524B1A3AA44Q27021279-7AF44B57-52F2-4976-ABF7-6F33A01768C7Q27468827-7BF77088-3576-4BDD-BEEE-3FD7B427A38FQ28743210-5E04F433-1381-41D7-A6AC-BB5E47169600Q29619510-0AB4AFF7-72F4-4C46-8BB8-D3E435AAD3F1Q31107462-5DBB81C1-B55A-4B7D-ACF7-6EBAEBC217ADQ33237376-C072CEC1-C780-4AF0-8890-C76A151EDBB1Q33402461-6A13FA12-85AE-4B0A-9AF0-788ED5DE05C1Q33429036-23346F82-83E7-4973-A34B-CB30465402ACQ33518390-F540C66E-E9A7-4172-9B51-110E3FBCDFEDQ33582135-A6257A2A-B0CD-42C6-9176-0F45B04000D6Q33724189-4A9004BE-457A-4B71-BC92-72DD57554D5DQ33758570-1B60BD17-03F0-4743-A870-F55611EACBD2Q33780649-CD66609D-B9C2-4674-A0C5-96CBD7BC036AQ33839456-3F9785A4-C8E6-43BA-A481-EADE7AD69D1AQ33843999-41A80DC1-99A8-4FDA-8632-4BE159619951Q33851266-40E841AD-3E70-4E56-BE73-3356896CA675Q33877419-2396195E-D501-45BB-BABD-ECEC17ACE0B6Q33883813-12F41F31-ED9D-4A4E-84B2-340418FDA595Q33886570-7FBB17E0-4E4C-4090-9FF0-F78D95E7D13AQ33911935-909ECCEB-6D48-4C42-A596-CACA1B286190Q33912015-77A227B5-5748-41AF-9E76-196CE2FAF73EQ33998976-42B10374-EF13-42FD-81F1-CBE7DB483571Q34038460-04496558-4321-40F9-A72D-29F95E585778Q34062608-2DCBF58D-CCA6-4A81-BC3C-6B78F1D4F5A0Q34147892-4F6424B6-815D-4731-A9A4-21C4BB59FDE2Q34158525-060E2629-FBB9-4AC9-9766-183BB004D1A2Q34243486-179E0028-B082-40BB-A3CB-BD874E39CDECQ34332009-14FD3022-EF8F-4C9D-9CAE-8C18DB2DC904Q34344788-CDAAE706-220B-495B-8B22-DBE7839D2BFBQ34349322-D4E7545F-0AA7-4709-84D2-13B1D0F22CCCQ34353398-FE7C6362-A737-4315-9757-030DC8EBE373Q34357324-E538EEF9-0619-4F5D-A8F2-75C3AF851F51Q34360562-039DFCAB-9D14-4910-9EA6-AE6AE5B9CB03Q34439417-F860F173-CA3A-44E0-A835-4EBF274ABE83Q34553124-35DAF84C-6166-4BB6-945E-8019FE2DF976Q34577539-3BAAF04E-CAC9-4487-9517-070CBC0669B8Q34608508-905AA146-3A9D-4533-9413-DDC610D68957
P2860
Gender differences in HIV-1 diversity at time of infection
description
2000 nî lūn-bûn
@nan
2000 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Gender differences in HIV-1 diversity at time of infection
@ast
Gender differences in HIV-1 diversity at time of infection
@en
Gender differences in HIV-1 diversity at time of infection
@nl
type
label
Gender differences in HIV-1 diversity at time of infection
@ast
Gender differences in HIV-1 diversity at time of infection
@en
Gender differences in HIV-1 diversity at time of infection
@nl
prefLabel
Gender differences in HIV-1 diversity at time of infection
@ast
Gender differences in HIV-1 diversity at time of infection
@en
Gender differences in HIV-1 diversity at time of infection
@nl
P2093
P2860
P3181
P356
P1433
P1476
Gender differences in HIV-1 diversity at time of infection
@en
P2093
D J Jackson
H L Martin
J K Kreiss
J Overbaugh
K Mandaliya
S M Rainwater
P2860
P2888
P3181
P356
10.1038/71563
P407
P577
2000-01-01T00:00:00Z
P5875
P6179
1022440151